Back to medications
Medication monograph

blinatumomab

Bispecific T-Cell Engager (BiTE) AntibodiesAntineoplastic AgentsBispecific CD19-directed CD3-directed T Cell EngagerChemotherapeutic Agents

Clinical reference

Product monograph

BLINCYTO- blinatumomab kit

Brands & formulations

Family members

BLINCYTO

Marketed
38.5 MCGINTRAVENOUSPOWDER FOR SOLUTION[ "blinatumomab" ]
Product monograph

Classification

Chemical class
Bispecific T-Cell Engager (BiTE) Antibodies
Clinical class
Antineoplastic Agents
Banks class
Bispecific CD19-directed CD3-directed T Cell Engager
AHFS family
Chemotherapeutic Agents